1 5 8 3 a r t I C l e S Genetic variation occurs not only as variation in the germline but also within the somatic cells of an individual, termed somatic mosaicism 1 . Somatic point mutations restricted to a subset of cells in the body cause a variety of neurological disorders, including Sturge-Weber syndrome 2 and hemimegancephaly 3 . It is now clear that somatic mosaicism is more common than previously thought and that this phenomenon is particularly prevalent in the brain. In 2005, Muotri et al. 4 discovered that L1 retrotransposons mobilize during neural development, despite the many cellular defenses that inhibit retrotransposition. L1 is an active mobile endogenous element capable of de novo insertions into new genomic locations 5 , leading to somatic mosaicism in the human hippocampus and other regions [6] [7] [8] [9] [10] [11] . Several studies, employing copy number qPCR assays, L1 reporter assays and next-generation sequencing of bulk and single cells, confirmed that somatic retrotransposition occurs during neural development and may be increased in neurons [6] [7] [8] [9] [10] [11] . Furthermore, striking levels of megabase-sized somatic copy number variants (CNVs) are present in neurotypical neurons 12, 13 . However, the levels of somatic mosaicism in different cell types and the types of somatic variants are not clearly defined.
a r t I C l e S Genetic variation occurs not only as variation in the germline but also within the somatic cells of an individual, termed somatic mosaicism 1 . Somatic point mutations restricted to a subset of cells in the body cause a variety of neurological disorders, including Sturge-Weber syndrome 2 and hemimegancephaly 3 . It is now clear that somatic mosaicism is more common than previously thought and that this phenomenon is particularly prevalent in the brain. In 2005, Muotri et al. 4 discovered that L1 retrotransposons mobilize during neural development, despite the many cellular defenses that inhibit retrotransposition. L1 is an active mobile endogenous element capable of de novo insertions into new genomic locations 5 , leading to somatic mosaicism in the human hippocampus and other regions [6] [7] [8] [9] [10] [11] . Several studies, employing copy number qPCR assays, L1 reporter assays and next-generation sequencing of bulk and single cells, confirmed that somatic retrotransposition occurs during neural development and may be increased in neurons [6] [7] [8] [9] [10] [11] . Furthermore, striking levels of megabase-sized somatic copy number variants (CNVs) are present in neurotypical neurons 12, 13 . However, the levels of somatic mosaicism in different cell types and the types of somatic variants are not clearly defined.
Somatic variants, particularly in noncancerous tissue, are difficult to identify because the alterations are present in only a fraction of cells, with some variants unique to a single cell. Single cell genomic analysis is a powerful technology to identify somatic variants, but the process of whole genome amplification introduces artifacts that make accurate identification challenging. This difficulty has resulted in conflicting estimates of the frequency of somatic L1 insertions in neurons: some estimates put the frequency as low as <0.04-0.6 L1 insertions per cell 6, 8 while others find as much as 13.7 L1 insertions per cell 9 .
Here we investigate the role of L1 in the creation of somatic mosaicism in the healthy brain. We developed a high-throughput sequencing method to specifically capture SLAVs in bulk tissue and single nuclei, which we refer to as SLAV-seq. We found that somatic events occur at a similar rate, ~0.58-1 events per cell, in both glia and neurons and affect 44-63% of the cells in the healthy brain. Somatic events occurred during a variety of neural development stages, including in an early progenitor cell that contributes to both hippocampus and frontal cortex. Other events occurred late in development and could only be detected in a single cell. We also demonstrate that a subset of SLAVs comprises somatic deletions generated by homologymediated mechanisms independent of retrotransposition.
RESULTS

Identification of SLAVs by single nuclei sequencing
Robust identification of SLAVs is instrumental in advancing our understanding of somatic retrotransposition in the human brain. A systematic identification of SLAVs has been challenging due to the low allele frequency of somatic variants and the amplification artifacts caused by whole genome amplification. Large numbers of amplification artifacts could be partially due to low coverage of somatic variants and insufficient sequence information. We therefore developed a targeted single-cell sequencing approach and machine learning-based analysis to identify SLAVs. SLAV-seq improves upon a r t I C l e S previous methods 6, 8, 9 by (i) increasing sensitivity and efficiency, leading to increased coverage; (ii) using a non-PCR-based method of fragmentation and adaptor ligation, allowing for better identification of unique molecules; (iii) allowing for more confident detection of novel insertions by employing paired-end sequencing, with one of the reads spanning the junction between L1 and the flanking genomic sequence; and (iv) employing a data-driven, machine-learning-based prediction of variants.
We sequenced whole-genome amplified single nuclei (n = 89) and bulk samples from the frontal cortex and hippocampus of three healthy individuals (Fig. 1a and Supplementary Table 1) . Single nuclei isolated from the brain were subjected to whole-genome amplification by multiple displacement amplification (MDA) 14 . Post-mortem brain nuclei were purified from mixed populations of cells using fluorescence-activated cell sorting after immunostaining for the neural-specific antigen NeuN (Supplementary Fig. 1 ). We employed multiple controls to confirm proper NeuN sorting, the presence of a single nucleus in each well, the absence of exogenous human DNA contamination and quality control for MDA products (Online Methods and Supplementary Fig. 1 ).
To generate genome-wide profiles of L1 insertions, SLAV-seq used ligation-mediated PCR techniques 15, 16 to allow split-read identification of the 3′ end of the most active L1 subfamily 17 by paired-end Illumina sequencing (Fig. 1b) . Using this approach, we classified each read pair as potentially originating from reference or nonreference insertions, depending on how well the initial portion of read 2 aligned with the reference genome and with the L1 consensus sequence (Fig. 1b) . SLAV-seq provided high sensitivity and specificity for reference and nonreference L1 insertions (Supplementary Fig. 2) .
To measure the sensitivity of this technique in identifying somatic variants, we asked what percentage of known nonreference germline loci (KNRGL) was detected within our single-cell data sets as a function of coverage (i.e., the number of nonredundant 3′ L1 junction reads identifying the insertion). In a single cell, a heterozygous polymorphic germline L1 insertion and a somatic L1 insertion are equivalent in allele frequency and thus equally detectable. We observed a median of 71% KNRGLs supported by five or more nonredundant reads, a median of 14% KNRGLs detected by 1-4 reads and a median of 15% KNRGLs not detected by any reads. Thus, SLAV-seq had high sensitivity in detecting L1 insertion variants, and we therefore applied a threshold of ≥5 nonredundant reads to identify SLAVs (Fig. 1c) .
To identify nonreference variants, we opted for a machine-learning approach in which the rules to separate real SLAVs from false positives were learned from examples within the data sets (Fig. 1d) . MDA and other amplification steps generate chimeric molecules 18 that can introduce false positives, which a data-driven machinelearning approach aims to distinguish by examining many features from the data. We mapped the sequencing reads against the reference genome hg19 using the Burrows-Wheeler Aligner-Maximal Exact Match (BWA-MEM) program 19 . We took advantage of BWA-MEM's support for split-read mapping to identify which portions of the reads mapped to L1 and which portions mapped to the flanking genome. We subdivided the genome into 750-bp windows with a 500-bp overlap. For each window, we collected 70 features such as total number of reads and number of reads mapping partially to L1 and partially to the genome (nonreference transposable element reads; Supplementary Table 2) . For each single-cell data set, we trained a random forest classifier 20 using as positive examples the windows containing KNRGLs covered by ≥5 nonredundant reads and, as negative examples, the subset of windows with ≥5 nonredundant reads from a set of 10,000 randomly drawn windows from the genome. The classifiers were evaluated by fourfold cross-validation and demonstrated highly accurate identification of nonreference germline insertions in bulk and single-cell samples. The median precision, which measures the specificity of the classifiers, was above 87% for L1 in bulk and single-nuclei samples (Supplementary Fig. 3a) . The median recall, which measures sensitivity, was above 70% for bulk and single-nuclei a r t I C l e S libraries (Supplementary Fig. 3b ). As expected, the random forest classifier selected the number of nonredundant reads that had a portion aligned to the retrotransposon and not to the genome (nonreference transposable element reads) as an important feature in identifying nonreference insertions (Supplementary Fig. 3c ).
To identify somatic insertions, we obtained the set of loci predicted to be nonreference variants and subtracted all previously annotated KNRGL (ref. 19 ) and private germline insertion loci found in the individuals (Supplementary Table 3) . Because false positives due to whole-genome amplification are enriched near known L1 loci 6,9 and our machine-learning approach does not use proximity to known L1 loci as a predictive feature, we subtracted candidates within 10 kb of germline L1HS, L1PA2, L1PA3 (evolutionarily young L1 families) and KNRGL to minimize false positives. Those genomic regions accounted for 9.3% of the genome and contained 170 putative SLAVs most likely to be false positives (Supplementary Table 4) . After subtracting these regions, our analysis identified 46 putative SLAVs in the single-nucleus samples from brain cells (Supplementary Table 5 ). A similar filter was imposed by previous single cell somatic L1 insertion identification studies. Putative L1 variants were identified in neurons and non-neurons from both hippocampus and frontal cortex.
SLAVs occur in progenitor cells, neurons and glia
To independently validate the L1 somatic candidates identified within single cells, we performed two PCR assays (Supplementary Table 5) followed by Sanger sequencing, again using features of polymorphic germline insertions to guide our true positive calls. The first assay confirmed the 3′ end of L1 using one primer complementary to the 3′ end of L1 paired with a primer complementary to the flanking genomic sequence. The second PCR assay involved primers complementary to the 5′ and 3′ sequences flanking the insertions, such that the L1 insertion generated a larger sized fragment for an insertion allele and a smaller band for the empty allele. This PCR strategy also confirmed that somatic insertions were not present in bulk genomic DNA (gDNA) from the individual, because all somatic candidates were undetected from bulk gDNA samples. After PCR, Sanger sequencing was performed on all amplified products.
We confirmed that somatic L1 retrotransposon insertions harboring target site duplication (TSD) occurred in neurons and glia. A TSD is a short direct repeat flanking both sides of the L1 sequence that occurs upon L1 retrotransposition insertion 5 . One insertion with validated TSD was identified in a hippocampal neuron from individual 5125 into Chr. 5: 147471250 ( Fig. 2a and Supplementary Table 5 ). This 1,336-bp L1HS insertion occurred in the 8th intron of SPINK5. The insertion used the canonical TT/AAAA endonuclease site with a 13-bp A homopolymer present in the reference genome. Because of the A stretch and homology to L1 sequence, we could not determine the exact length of TSD, but it was between 2 and 7 bp. A second 1,593-bp L1HS insertion with TSD was found in a frontal cortex NeuN-negative nucleus located in the second intron of ADCY1. This insertion also used the canonical endonuclease TT/AAAA site and contained a 3-bp TSD ( Fig. 2b and Supplementary Table 5) .
If the somatic L1 insertions occurred in a progenitor cell, the unique variant could be used to trace the progenitor cell's developmental contribution to the brain 7 . We applied droplet PCR assays to quantify the percentage of cells harboring SLAVs in the bulk tissue from frontal cortex, hippocampus or cerebellum from the same individual ( Fig. 2c and Supplementary Table 5 ). Digital PCR overcame the limitations of standard PCR assays to accurately detect rare nucleic acid sequences 7, 21 . The digital PCR assay involved partitioning samples into a large number of small droplets before amplification.
After amplification with a TaqMan fluorescence probe for the junction of the 3′ end of L1 and the unique insertion location, the fluorescence of each droplet was read. For the neuronal insertion into Chr. 5: 147471250, the insertion was specifically detected in the amplified single cell and corresponding bulk hippocampal and cerebellar DNA from that individual (Fig. 2d) . Approximately 0.5% of the cells in the hippocampus and cerebellum harbored the L1 insertion, suggesting that it occurred in a progenitor that gave rise to cells of the hippocampus and cerebellum. The hippocampal glia insertion into Chr. 7: 45646250 was detected only in the amplified single cell DNA and was, therefore, unique to the single cell or present in less than 0.1% of the cells, the detection limit of the assay ( Fig. 2e and Supplementary Fig. 4 ). All SLAVs were below the detection limit for standard PCR assays in bulk tissue, confirming that they were not germline variants.
A portion of SLAVs lack TSD Of 15 loci tested, 11 passed 3′ PCR validation, whereas two L1 insertions passed 3′ PCR and flanking PCR validation with Sanger sequencing-demonstrated TSDs ( Fig. 3a and Supplementary Table 5) . As a reference, 80% of full-length heterozygous germline loci passed the flanking PCR assay (Supplementary Fig. 5 ). This PCR and sequencing strategy is similar to that used in a previous report for identifying somatic L1 insertions in single cells 6 but achieved a higher true-positive validation rate (73% versus 21% for 3′ PCR and 13% versus 1% for flanking PCR), likely because our data were paired-end with L1 split read information. (Comparison with other PCR validation strategies is discussed in Supplementary Fig. 6 .)
We next asked if the variant calls with confirmed 3′ L1HS sequence but lacking TSD could be detected in bulk tissue, which would indicate that the variants existed in a subset of cells in the individual and were not merely artifacts. Of the nine variants validated exclusively on the 3′ side, three were detected by digital PCR in bulk tissue, three were not detected in bulk tissue and three failed assay design ( Fig. 3b and Supplementary Table 5 ). The five variants detected in single cells and bulk tissue were found in <0.01% of the cells from the corresponding bulk hippocampus. They were not detected in corresponding cerebellum or in HeLa negative controls. Variants occurred in DLG2, PLCZD3 and intergenic regions.
For three loci validated in bulk tissue, we asked if another form of genomic variation besides retrotransposition-dependent insertion with TSD could have occurred. Exogenous retrotransposition assays have previously demonstrated that L1 retrotransposition can create genetic instability, including the generation of chimeric L1s, intrachromosomal deletions, intrachromosomal duplications and intra-L1 rearrangements 22, 23 . If the L1 variants were associated with a deletion in the single cell, this would result in a loss of heterozygosity 5′ of the variant (Fig. 3c) . For two of the three variants assayed, loss of heterozygosity occurred. Heterozygous single-nucleotide polymorphisms were detected in the bulk tissue and a loss of heterozygosity was detected in the single-cell DNA at the sequence 5′ upstream of the variant. Notably, allele dropout did occur in other single cells, but only the single cell with the identified SLAV contained loss of heterozygosity (LOH) for all loci assayed within the putative deletion region. For the third variant at 3p12.2, both the bulk gDNA and single-cell DNA had heterozygous single-nucleotide polymorphisms, indicating no deletion.
L1 sequences are hotspots for CNVs created by L1 endonuclease For the two loci indicating loss of heterozygosity, we successfully identified the deletion junction for both variants (Fig. 4 and Supplementary Table 5 ). For the variant at 7q31.1 ( Fig. 4a anda r t I C l e S Supplementary Table 5 ), we performed a flanking PCR assay with primers walking 5′ upstream of the variant location paired with a fixed primer outside of the L1 sequence in the 3′ unique sequence (Fig. 4a) a r t I C l e S DNA was tested by PCR and Sanger sequencing, the deletion variant was also confirmed specifically in the corresponding bulk genomic hippocampal DNA, confirming that the variant occurred in a progenitor cells and was detectable in unamplified material. As an additional confirmation of the deletion variant, we subjected a portion of the MDA-amplified single cell genomic DNA that was used for SLAV-seq to shallow whole-genome sequencing. Consistent with previous reports 24 , we observed high variability in the normalized read count per 500-kb bin across the genome (coefficient of variation (standard deviation divided by the mean) of 0.65, 0.77 and 1.01 for samples 48, a r t I C l e S 53 and 153, respectively) due to unequal amplification from single-cell whole-genome amplification (Supplementary Fig. 7 ). Nevertheless, we observed a reduction in normalized read counts at position Chr. 7: 108.7-109.5 MB, consistent with the SLAV found in that position in sample 153 (Fig. 4a) .
A similar strategy was used to characterize the deletion junction of the 15q11.2 variant. For the variant at 15q11.2, a 1.3-kb PCR band was detected specifically in the single-cell DNA when a primer 40 kb upstream of the variant was paired with a primer just 3′ of the L1 sequence (Fig. 4b) . Unfortunately, we exhausted the matched hippocampal tissue. Therefore, a higher concentration of bulk hippocampal tissue could not be tested by this flanking PCR. For the single cell, Sanger sequencing indicated that a 39.6-kb deletion between two A homopolymer sequences occurred (Supplementary Table 5 ). The upstream A homopolymer was from a reference L1HS poly-A tail that recombined with a downstream A homopolymer sequence, resulting in deletion of the PWRN2 gene.
Unexpectedly, the 15q11.2 and 7q31.1 variants occurred independently of retrotransposition. No additional sequence was present, indicating no incorporation of reverse-transcribed cDNA. Cleavage at the L1 endonuclease motifs 25 could have mediated the deletion, although other mechanisms could result in a similar deletion. In summary, we discovered that a subset of SLAVs lacked TSD and were somatic deletions that likely occurred independent of retrotransposition.
Deletions of genes involved in neuronal differentiation or function may alter proper function. To reveal potential biological consequences of SLAVs, we modeled the hippocampal 15q11.2 deletion of PWRN2 in vitro using human embryonic stem cell-derived hippocampal progenitor cells 2 . Using RNA-seq, we assayed for transcriptomewide changes caused by decreased PWRN2 expression. PWRN2 knockdown resulted in significant disruption of nervous system development-related genes. The significantly differentially expressed genes (adjusted P-value, P adj < 0.01; Supplementary Table 6) were enriched in neuronal differentiated Gene Ontology categories, such as nervous system development (Gene Ontology: 0007399, adjusted P-value, P adj = 0.00032; Fig. 4c) . We confirmed efficient knockdown in these samples by quantitative reverse transcription polymerase chain reaction (qRT-PCR), which demonstrated 28-63% PWRN2 transcripts remaining in knockdown samples compared to scramble controls (Fig. 4d) .
To discover the mechanism generating SLAVs, we asked if genomic L1 sequences are prone to instability. L1 retrotransposons encode for an endonuclease 26 . In addition, L1 DNA sequences harbor the preferential sequence motif recognized by the endonuclease they encode 25 . Therefore, the increased expression of L1 protein during neurogenesis 5, 8 may have caused excessive DNA damage at genomic L1 DNA sequences that resulted in retrotransposition-independent SLAVs preferentially occurring at germline L1 sequences during neural development. First, we assayed the expression pattern in an in vitro human embryonic stem cell differentiation system of human hippocampal neural differentiation of L1 ORF2, which harbors endonuclease and reverse transcriptase domains (Fig. 5a) . Consistent with previous reports in pan neuronal differentiation 8 , L1 ORF2 was highly upregulated during the initial stages of hippocampal neural progenitor cell differentiation toward neurons. In addition, L1 transcript levels return to a high level at later development stages, when most cells are post-mitotic 27 .
Next, we asked if L1 overexpression creates double-strand DNA (dsDNA) damage preferentially at germline L1 genomic loci. We overexpressed a functional L1 23, 26, 28 and visualized dsDNA damage by γ-H2AX, which is associated with double-strand break (DSB) ends 29 . This confirmed that L1 overexpression results in an increase in dsDNA damage as visualized by γ-H2AX (Fig. 5b) 30 . We determined where L1-induced dsDNA damage was localized by chromatin immunoprecipitation for γ-H2AX or IgG negative controls (Fig. 5c) . We observed a specific increase in γ-H2AX localization at genomic L1 loci upon L1 overexpression, which is absent for endonuclease and reverse-transcriptase-deficient L1 overexpression and for H 2 O 2 oxidation-induced DNA damage. Therefore, L1-associated genomic regions are predisposed to somatic CNVs in the brain. The increased expression of L1 endonuclease during neural differentiation induced dsDNA breaks preferentially at L1 loci.
We next asked what the average rate and distribution of variants were per cell and cell type. We plotted the number of SLAVs identified a r t I C l e S in each cell (Fig. 6a) . To correct for cell-specific variation in amplification and library preparation, we normalized by the fraction of KNRGL detected. For neurons, we obtained 0.91 and 0.83 mean normalized somatic insertions per cell for hippocampus and frontal cortex, respectively. For glial cells, we obtained 1.66 and 0.78 mean normalized variants per cell for hippocampus and frontal cortex, respectively. Unexpectedly, neurons and glia harbored similar numbers of SLAVs (no significant difference, Mann-Whitney U test, one-sided P-values: hippo_NeuN − versus hippo_NeuN + : P = 0.12; hippo_NeuN − versus cortex_NeuN + : P = 0.24; hippo_NeuN − versus cortex_NeuN − : P = 0.09; hippo_NeuN + versus cortex_NeuN + : P = 0.39; hippo_NeuN + versus cortex_NeuN − : P = 0.28; cortex_NeuN + versus cortex_NeuN − : P = 0.24), in contrast to previous reports 9 . We next asked if SLAVs were equally distributed among all cells in the brain or if a subset of cells harbored a large number of SLAVs. The number of SLAVs per cell fit a Poisson distribution (no significant deviation from Poisson distribution, χ 2 test: n = 5, χ 2 = 5.13, P = 0.26), indicating a similar probability for any cell to contain a SLAV (Fig. 6b) . SLAVs also demonstrated a significant enrichment to occur in reference L1 and Alu sequences (Fig. 6c) (P = 0.016 for Alu, P = 0.022 for L1; exact binomial test). No SLAVs occurred within protein coding exons, but SLAVs occurred within protein-encoding genes, which include introns and exons, at the expected frequency.
To estimate the rate and type of SLAVs per cell, we incorporated PCR validation rates and detection of KNRGL. For all cells in the brain, we estimate a prevalidation base rate of 1.07 SLAVs per cell by combining the prevalidation rates of all cells, corrected for the respective KNRGL detection rates. We estimated the upper bound of 1 SLAV per cell by multiplying the prevalidation base rate by the 3′ validation rate (75% or 12 out of 16) and dividing by the rate of germline validation (80%). The lower bound estimate of 0.58 SLAV per cell was calculated by multiplying the base prevalidation rate with the fraction of insertions passing flanking PCR or digital droplet PCR of (43.8% or 7 of 16) and dividing by the 80% germline validation rate. Since the number of SLAVs per cell was well approximated by a Poisson distribution, we estimated the upper and lower bound fraction of cells containing at least one SLAV to be 44-63% of cells by Pr (x > 0) = 1 − e −λ for a Poisson distribution with rate parameter λ given by the upper and lower bound estimates. Unexpectedly, we found that approximately half of the SLAVs might occur independently of retrotransposition.
DISCUSSION
Using SLAV-seq and independent validation, our study revealed that L1 sequences generate somatic mosaicism in the brain through both retrotransposon insertions and retrotransposition-independent structural variants mediated by L1 endonuclease. Previously, singlecell sequencing revealed that a subset of neurons from neurotypical individuals harbored large CNVs that were between 500 kb and 1 Mb in size 12, 13 , but the state-of-the-art methods of the time lacked the sensitivity to detect CNV junction sequences. Therefore, the mechanism generating these large somatic CNVs could not be determined. Our data suggest that L1 sequences are prone to dsDNA damage as a result of L1 upregulation during neural differentiation that can generate somatic CNVs in the brain (Fig. 5 and Supplementary Fig. 8) . Previous single-cell somatic L1 retrotransposition studies had estimated rates of <0.04-0.6 L1 insertions per cell 6,8 or 13.7 L1 insertions per cell 9 . In order to accurately estimate the rate of SLAVs in the brain, the full repertoire of variant types must be known. In addition to differences between the previous approaches 6, 8, 9 , the presence of variants with genomic features similar to those of somatic L1 insertions likely contributed to differences in rate estimates.
By identifying a heritable component that contributes to somatic mosaicism, we reveal the potential for features of somatic mosaicism to be subjected to natural selection, suggesting a heritable genetic state with regions of the genome predisposed to somatic CNVs in the brain. Genomic regions near fixed L1 sequences may have a propensity for somatic CNVs in the brain. Individuals with different germline L1 sequences may differ in their mosaic SLAV composition, but our findings predict that the mosaic SLAV composition could be similar between related individuals.
Considering the size of retrotransposition-independent SLAVs, some of which result in large deletions, we propose that SLAVs have the potential to significantly impact gene expression for the lineage of cells containing the SLAV. We previously reported that the retrotransposition of an engineered human L1 into the DLG2 gene led to its overexpression, which influenced the differentiation pattern of neural precursor cells 4 . Here we report an endogenous SLAV within the same gene, DLG2, which occurred in hippocampal progenitor cells. DLG2 plays a crucial role in complex learning, cognitive flexibility and attention 31 . Mutations in DLG2 have been associated with schizophrenia in several independent studies 32, 33 . Therefore, SLAVs can occur in important neural genes, and we suggest that DLG2 may be a hotspot for SLAVs.
Previous studies have demonstrated that brain-specific somatic mutations can cause significant phenotypic variations 1, 3 . For example, somatic mTOR mutations that are undetectable in blood and present in <10% of the cells in the focal dysplastic regions have been shown to cause focal cortical dysplasia type II in several patients 34 . In addition, small percentages of cells can affect network activity. In rodents, depleting the hippocampus of adult-born immature neurons, n.s.
n.s. a r t I C l e S which represent >0.5% of the dentate gyrus 35 , causes defects in pattern separation, memory discrimination and contextual memory consolidation 36 . Future experiments will help reveal if somatic mosaicism is particularly relevant to brain function, where small groups of cells (or even individual cells) can affect network activity.
METhODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. Pellets were resuspended in nuclei storage buffer (5 mM MgCl 2 , 50 mM Tris-Cl, 166 mM sucrose, 1 mM DTT, and 1 × protease inhibitor cocktail). Free nuclei and purity were confirmed visually using microscopy. Neuronal nuclei were purified from bulk brain nuclei using NeuN immunostaining. Immunostaining was performed for 1 h at 4 °C with gentle agitation in PBS containing 5 µg/mL (1:2,000) AF488-conjugated NeuN antibody (Millipore, MAB377). Nuclei were then stained for DNA content with 10 µg/mL DAPI and analyzed by FACS. Single nuclei (94) from the NeuN-and DAPI-positive population were sorted into 384-well plates containing lysis buffer alongside two water controls (containing lysis buffer but no nuclei), such that all nucleus-containing wells were surrounded by empty wells to avoid cross contamination. During the FACS process, additional single nuclei that did not receive MDA amplification were sorted into 384-well plates. These plates were subjected to TaqMan qPCR assays of L1 ORF2 to calculate the sorting efficiency. For all sorts, >95% of wells contained 0 or 1 nucleus.
whole genome amplification and quality control. Genomic DNA was amplified via multiple displacement amplification (MDA) using phi29 polymerase (GenomiPhi HY, GE Healthcare, Piscataway, NJ), as described 14 . Single nuclei were sorted into 1.5 µL of lysis buffer (0.2 M KOH, 0.05 M DTT), incubated on ice for 10 min and then at 65 °C for 10 min, then a 4 °C hold. Once at 4 °C, 9 µL of sample buffer, 9 µL reaction buffer and 1 µL phi29 enzyme were added. Reactions were incubated at 30 °C for 16 h and then inactivated at 65 °C for 10 min. MDA products (5 ng) were examined for sufficient amplification (for example, +/−5% of the Ct for 5 ng bulk genomic DNA) using qPCR (Applied Biosystems, San Diego, CA). To test for sufficient amplification, we used a four-locus subset of the 47 single copy loci used in Hosono et al. 37 (here, Chr3q, Chr7p, Chr11p, Chr14q) for MDA quality control. MDA products were also quantified by Picogreen (Life Technologies). Water control products were analyzed for human DNA contamination using L1 ORF2 #2 TaqMan qPCR (Life Technologies) 10 . Once nuclei passed these QC, they were randomly selected to be prepared into libraries. All preamplified material was handled in a separate single-cell room in a laminar flow hood. All materials used in preamplification (excluding the enzyme, sample buffer and reaction buffer) were UV sterilized before use. library preparation and sequencing. Version 1. Genomic DNA and MDA samples were processed identically after the amplification step. Ten µg of DNA were sheared to an average size of 500 bp via sonication using a Covaris S2 sonicator (5% duty cycle, intensity of 3,200 cycles per burst, 80 s total time. DNA was then concentrated using Agencourt Ampure beads (Beckman Coulter) and L1 capture was performed with a single anneal and extension step with platinum Pfx DNA polymerase (Invitrogen) and biotinylated L1 oligo: 5′-biotin-TGGGAGATATA CCTAATGCTAGATGACAC*A-3′, where the asterisk denotes phosphorothioate linkages (94 °C for 5 min, annealed at 61.5 °C for 30 s, 68 °C extension: 3 min). The reaction was cleaned up with Agencourt Ampure beads, and end-repaired (NEB end-repair kit). Size was selected on 1.5% pippin prep gel (Sage Bioscience). Biotinylated fragments were incubated with streptavidin magnetic beads (Dynabeads MyOneTM Streptavidin C1, Life Technologies, Inc., Carlsbad, California, USA); a 3′ A overhang was added to bead-DNA (NEB dA-tailing module). Adaptor ligation was then performed on bead-attached DNA with ultrapure T4 DNA ligase (Enzymatics) using the following custom asymmetric annealed oligos: JE117: 5′AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACA CGACGCTCTTCCGATC*T-3′; JE149: 5′-/P/GATCGGAAGAGCG/3AmM/-3′, where /P/ denotes a phosphate group and /3AmM/ denotes an amino group. All custom oligonucleotides were synthesized by Integrated DNA Technologies (Coalville, Iowa) and HPLC purified. The adaptor ligated-bead-DNA was washed 3×, resuspended in 10 mM Tris-Cl, pH 8.5, and PCR-amplified for 16 cycles (KAPA HiFi HotStart ReadyMix, Kapa Biosystems Wilmington, MA) with the following oligo (NNNNNN denotes barcode):
L1: 5′-CGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCTN (3-10) ATGTGCACATGTACCCTAAAACTT*A-3′.
These PCR products were purified away from bead DNA and size selected for 250-650 bp on 1.5% pippin prep agarose gels. Each library was analyzed on a Bioanalyzer DNA HS chip (Agilent Technologies, Inc., Santa Clara, CA, USA) and further size selections were performed manually when necessary on 2% agarose gels. A whole flow cell of Illumina HiSeq200 100-bp paired-end sequencing was performed at McGill University and Genome Quebec Innovation Centre.
Version 2. Version 1 was updated to perform targeted sequencing using standard Illumina sequencing primers. Modifications were also made to increase throughput. Ten µg of MDA and gDNA were sheared by Covaris E220 and concentrated with Ampure beads as in version 1. Five µg of DNA were aliquoted for L1 3′ library generation. Capture, extension, A-tailing and ligation proceeded as before except the L1 capture proceeded with the following oligo:
JE281L1_ACA: /5biosg/ATATACCTAATGCTAGATGACAC*A. Custom asymmetric annealed oligos/adapters were used: JED501+JED50x_lig: 5′-AATGATACGGCGACCACCGAGATCTACACNNN NNNNNACACTCTTTCCCTACACGACGCTCTTCCGATC*T-3′ annealed to:
JED50x_lig: /5Phos/GATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT/ 3AmM/-3′.
PCR amplification proceeded as before for 16 cycles but with the following PCR primers:
L3′: JE502-517 (5′-CAAGCAGAAGACGGCATACGAGANNNNNNNGTGA CTGGAGTTCAGACGTGTGCTCTTCCGATCTNTAACTAACCTGCACAAT GTGCAC-3′) + JE620 (5′-AATGATACGGCGACCACCGAGATCTACAC-3′).
Size selection was performed via double Ampure purification. Libraries were quantified using Picogreen (Life Technologies) and qPCR and were mixed with 10-20% PhiX and sequenced on Illumina HiSeq2500 at the Salk Genomics Core. computational analysis. Preprocessing and mapping. Reads were trimmed with the Cutadapt program (version 1.3) to remove adaptor sequences and 3′ ends having Phred qualities smaller than 28. Read pairs having one read smaller than 36 bp after trimming were also discarded. Trimmed reads were mapped to the reference human genome hg19 with BWA-MEM (ref. 19; version 0.7.5a) in paired-end mode with parameter -T 19. Read pairs sharing the same end coordinates were treated as PCR duplicates, and only the pair with the highest total sequence quality score was retained. The first k bp of read 2 (k = 29 for SLAV-seq v2 (applied to all single cells and most bulk samples), k = 12 for SLAV-seq v1 (applied to some bulk samples)) were aligned to the last k bp of L1HS consensus, for L1. If the read pair was mapped in proper pairing, the first k bp of read 2 were aligned to k+2 bp of the local genomic sequence, anchored to the read 2 mapping position. Otherwise, the first k bp of read 2 were aligned to 750 bp of the local genomic sequence, anchored to the read 1 mapping position. These alignments were done with a modified Needleman-Wunsch pairwise alignment algorithm 38 with the following scoring parameters: match: 1, mismatch: −1, gap opening: −5, gap extension: −1 and terminal gap: 0. This resulted in two alignment scores: YA, alignment of read 2 prefix to retrotransposon consensus; and YG, alignment of the read 2 prefix to the local genome sequence. SLAV-seq data have been deposited at EMBL-EBI ArrayExpress and are accessible through accession code E-MTAB-3880.
machine-learning approach to identify l1 insertions. We split the reference genome hg19 into equally spaced 750-bp windows with an overlap of 500 bp between consecutive windows. For each window, we collected 70 features, listed in Supplementary Table 2 . For each single cell or bulk tissue sample data set, we trained a random forest classifier 20 with the objective of predicting whether or not each window had an insertion. We used as positive examples the windows containing previously known nonreference L1 polymorphic insertions covered data availability. The data that support the findings of this study are available in excel Supplementary Tables 1-6 and from the corresponding author upon reasonable request. Sequence data sets for SLAV-seq, whole genome sequencing and RNA-seq were submitted to EBI ArrayExpress with accession codes E-MTAB-3880, E-MTAB-4824 and E-MTAB-4830, respectively.
Statistics. All information related to statistical tests is documented in the corresponding figure legends and/or in the main text and in a Supplementary methods checklist. Sample sizes were chosen to be similar to those generally employed in the field. Data collection and analysis were not performed blind to the conditions of the experiments.
